AMERICAN JOURNAL OF NEURORADIOLOGY, vol.25, no.5, pp.819-826, 2004 (SCI-Expanded)
BACKGROUND AND PURPOSE: Papaverine is the primary intra-arterial (IA) treatment for vasospasm after aneurysmal subarachnoid hemorrhage (SAH); however, is it limited in effect and by adverse effects. We prospectively studied the use of IA nicardipine as a treatment for vasospasm.